Nightingale Health completes the analysis of all 500,000 UK Biobank samples creating the world's largest blood biomarker database for chronic disease research and prevention
Press release, 13 December 2023 at 8:30 a.m. (EET)
Nightingale Health Plc ("Nightingale Health"), a technology company promoting preventative health with its proprietary health risk detection platform, announced today that it has completed the analysis of blood samples from all 500,000 UK Biobank participants. UK Biobank is the world's most comprehensive source of health data used for research, renowned for its vast and continuously growing dataset of biological, health and lifestyle information.The de-identified data is globally accessible to approved researchers who are